AI-generated summary
The authors describe a single dog with osteosarcoma who developed phlebitis after doxorubicin chemotherapy, confirmed by ultrasound. Treatment combined corticosteroids, oral medications and low-level laser therapy, with clinical improvement reported, though phlebitis later appeared in other veins. The report is a single case, so its findings cannot be generalized.
- Who or what was studied
- One 7-year-old neutered male Golden Retriever with osteosarcoma of the left radius treated with amputation and adjuvant chemotherapy
- Limits stated in the abstract
- The report describes a single animal case, so no conclusions about effectiveness or frequency can be drawn.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
A 7-year-old neutered male Golden Retriever diagnosed with osteosarcoma of the left radius underwent limb amputation followed by adjuvant chemotherapy utilizing alternating carboplatin-doxorubicin protocols. Following doxorubicin administration, the patient exhibited localized heat, swelling, pain, and lameness in the right forelimb, indicative of phlebitis. Ultrasonography confirmed chemotherapy-induced phlebitis with thickening of the right cephalic vein wall, intraluminal thrombi, and significant perivascular edema. Treatment involved anti-inflammatory corticosteroids, oral medications (clopidogrel, pentoxifylline, doxycycline, vitamin E), and low-level laser therapy (LLLT), achieving clinical improvement. Despite successful control of chronic inflammation in the cephalic vein, phlebitis subsequently developed in other veins, including the right common dorsal digital vein and left saphenous vein, despite varying vascular access points. The patient showed clinical improvement with the combined use of oral medication and low-level laser therapy. The chemotherapy regimen was completed successfully without osteosarcoma recurrence, and the patient remained stable for over 13 months post-treatment. Following discontinuation of chemotherapy and supportive care, no further progression of phlebitis occurred. To the authors' knowledge, this report represents the first documented veterinary case of chemotherapy-induced phlebitis in a dog. While extensively reported in human oncology, chemotherapy-induced phlebitis remains underreported in veterinary medicine. Clinicians should recognize phlebitis as a potential complication associated with chemotherapeutic agents such as doxorubicin and carboplatin. Ultrasonography serves as an essential diagnostic and monitoring tool. Prophylactic corticosteroids and adjunctive low-level laser therapy offer promising preventative and therapeutic strategies, particularly for patients with predisposed vascular inflammation. This case underscores the importance of early identification, proactive management, and individualized treatment approaches to chemotherapy-associated phlebitis in veterinary oncology.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Case report, Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.